Japan Clinical Trial Supplies Market Size & Outlook
Japan clinical trial supplies market, 2018-2030 (US$M)
Related Markets
Japan clinical trial supplies market highlights
- The Japan clinical trial supplies market generated a revenue of USD 88.4 million in 2023 and is expected to reach USD 149.7 million by 2030.
- The Japan market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2023.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Clinical trial supplies market data book summary
| Market revenue in 2023 | USD 88.4 million |
| Market revenue in 2030 | USD 149.7 million |
| Growth rate | 7.8% (CAGR from 2023 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III |
| Key market players worldwide | Almac Group, Catalent Inc, Waldencast PLC Class A, PCI Technology, Sharp Corp, Thermo Fisher Scientific Inc, PAREXEL, Marken, KLIFO, BioCair |
Other key industry trends
- In terms of revenue, Japan accounted for 3.4% of the global clinical trial supplies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China clinical trial supplies market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 149.7 million by 2030.
Phase iii was the largest segment with a revenue share of 53.39% in 2023. Horizon Databook has segmented the Japan clinical trial supplies market based on phase i, phase ii, phase iii covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has been one of the major attractions for biopharmaceuticals and global CROs due to advancements in technology, policy reforms, faster recruitment of patients, and presence of a developed R&D infrastructure. These factors are expected to drive clinical research, which is expected to further increase the demand for efficient supply chain, thereby propelling growth of clinical trial supplies market in this country.
Pharmaceutical and Medical Device Agency, the regulatory body in Japan, has streamlined the review and approval process of drugs, which is anticipated to attract biopharmaceutical companies to conduct trials and promote entry of clinical trial supplies players. These factors are expected to contribute to the growth of Japan clinical trial supplies market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Supplies Market Scope
Clinical Trial Supplies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan clinical trial supplies market size, by phase, 2018-2030 (US$M)
Japan Clinical Trial Supplies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
